Literature DB >> 24777816

[A case report of the difficulty treating an endstage oncologic ENT patient with parenteral nutrition].

Ulrike Uxa-Benold1, Ralph Simanek, Annette Henry, Dietmar Weixler, Klaus Geissler.   

Abstract

The occurrence of cachexia at the end of life of patients suffering from cancer is a common seen problem. Within the last years new definitions, diagnostic criteria and classification systems of cachexia have been developed to improve the clinical practice. Still therapeutic interventions are limited; the role of parenteral nutrition (PN) remains controversial. PN cannot be generally recommended in patients with incurable malignancies, not even in ill-nourished patients with inadequate oral or enteral nutrition due to a changed metabolism. Treating a cachectic endstage patient suffering from head-neck-cancer we were faced with different problems.

Entities:  

Mesh:

Year:  2014        PMID: 24777816     DOI: 10.1007/s10354-014-0276-y

Source DB:  PubMed          Journal:  Wien Med Wochenschr        ISSN: 0043-5341


  11 in total

Review 1.  The cancer anorexia/weight loss syndrome: therapeutic challenges.

Authors:  Karin F Giordano; Aminah Jatoi
Journal:  Curr Oncol Rep       Date:  2005-07       Impact factor: 5.075

2.  Parenteral hydration in patients with advanced cancer: a multicenter, double-blind, placebo-controlled randomized trial.

Authors:  Eduardo Bruera; David Hui; Shalini Dalal; Isabel Torres-Vigil; Joseph Trumble; Joseph Roosth; Susan Krauter; Carol Strickland; Kenneth Unger; J Lynn Palmer; Julio Allo; Susan Frisbee-Hume; Kenneth Tarleton
Journal:  J Clin Oncol       Date:  2012-11-19       Impact factor: 44.544

3.  Dronabinol versus megestrol acetate versus combination therapy for cancer-associated anorexia: a North Central Cancer Treatment Group study.

Authors:  Aminah Jatoi; Harold E Windschitl; Charles L Loprinzi; Jeff A Sloan; Shaker R Dakhil; James A Mailliard; Sarode Pundaleeka; Carl G Kardinal; Tom R Fitch; James E Krook; Paul J Novotny; Brad Christensen
Journal:  J Clin Oncol       Date:  2002-01-15       Impact factor: 44.544

Review 4.  Megestrol acetate for the treatment of anorexia-cachexia syndrome.

Authors:  E G Berenstein; Z Ortiz
Journal:  Cochrane Database Syst Rev       Date:  2005-04-18

Review 5.  Definition and classification of cancer cachexia: an international consensus.

Authors:  Kenneth Fearon; Florian Strasser; Stefan D Anker; Ingvar Bosaeus; Eduardo Bruera; Robin L Fainsinger; Aminah Jatoi; Charles Loprinzi; Neil MacDonald; Giovanni Mantovani; Mellar Davis; Maurizio Muscaritoli; Faith Ottery; Lukas Radbruch; Paula Ravasco; Declan Walsh; Andrew Wilcock; Stein Kaasa; Vickie E Baracos
Journal:  Lancet Oncol       Date:  2011-02-04       Impact factor: 41.316

Review 6.  Cancer-associated cachexia and underlying biological mechanisms.

Authors:  Vickie E Baracos
Journal:  Annu Rev Nutr       Date:  2006       Impact factor: 11.848

7.  ESPEN Guidelines on Parenteral Nutrition: non-surgical oncology.

Authors:  F Bozzetti; J Arends; K Lundholm; A Micklewright; G Zurcher; M Muscaritoli
Journal:  Clin Nutr       Date:  2009-05-23       Impact factor: 7.324

Review 8.  Evolving classification systems for cancer cachexia: ready for clinical practice?

Authors:  David Blum; Aurelius Omlin; Ken Fearon; Vickie Baracos; Lukas Radbruch; Stein Kaasa; Florian Strasser
Journal:  Support Care Cancer       Date:  2010-03       Impact factor: 3.603

Review 9.  Is there a role for hydration at the end of life?

Authors:  Shalini Dalal; Egidio Del Fabbro; Eduardo Bruera
Journal:  Curr Opin Support Palliat Care       Date:  2009-03       Impact factor: 2.302

Review 10.  Catabolic mediators of cancer cachexia.

Authors:  Michael J Tisdale
Journal:  Curr Opin Support Palliat Care       Date:  2008-12       Impact factor: 2.302

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.